These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38007705)

  • 21. Significance of Chr9p22.1-p21.3 Deletion in Cancer Development: A Pan-cancer
    Gonçalves PG; Reis RM; Bidinotto LT
    Anticancer Res; 2022 Nov; 42(11):5291-5304. PubMed ID: 36288884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues.
    Zhang J; Lu T; Lu S; Ma S; Han D; Zhang K; Xu C; Liu S; Gan L; Wu X; Yang F; Wen W; Qin W
    Comput Struct Biotechnol J; 2023; 21():665-676. PubMed ID: 36659929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-Cancer Analysis on the Oncogenic Role of Programmed Cell Death 10.
    Sun N; Li C; Teng Y; Deng Y; Shi L
    J Oncol; 2022; 2022():1242658. PubMed ID: 36276268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatics and survival analysis of glia maturation factor-γ in pan-cancers.
    Lan A; Ren C; Wang X; Tong G; Yang G
    BMC Cancer; 2021 Apr; 21(1):423. PubMed ID: 33863293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.
    Zhang Z; Li L; Li M; Wang X
    Comput Struct Biotechnol J; 2020; 18():2438-2444. PubMed ID: 32905022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-SMC condensin I complex subunit D2 (NCAPD2) reveals its prognostic and immunologic features in human cancers.
    Dong X; Liu T; Li Z; Zhai Y
    Aging (Albany NY); 2023 Jul; 15(14):7237-7257. PubMed ID: 37498296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pan-cancer analysis of G6PD carcinogenesis in human tumors.
    Liu B; Fu X; Du Y; Feng Z; Chen R; Liu X; Yu F; Zhou G; Ba Y
    Carcinogenesis; 2023 Aug; 44(6):525-534. PubMed ID: 37335542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
    Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Good or not good: Role of miR-18a in cancer biology.
    Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
    Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential Expression of the
    Hu J; Xu J; Feng X; Li Y; Hua F; Xu G
    Front Cell Dev Biol; 2021; 9():700661. PubMed ID: 34631699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of cuproptosis-related gene DLAT in various cancers: a bioinformatic analysis and preliminary verification on pro-survival autophagy.
    Yang Q; Zeng S; Liu W
    PeerJ; 2023; 11():e15019. PubMed ID: 36949759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pan-Cancer Analysis Revealed
    Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
    J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MARCO is a potential prognostic and immunotherapy biomarker.
    Dong Q; Zhang S; Zhang H; Sun J; Lu J; Wang G; Wang X
    Int Immunopharmacol; 2023 Mar; 116():109783. PubMed ID: 36773567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of APOBEC3C in modulating the tumor microenvironment and stemness properties of glioma: evidence from pancancer analysis.
    Zhang S; Guo Y; Hu Y; Gao X; Bai F; Ding Q; Hou K; Wang Z; Sun X; Zhao H; Qu Z; Xu Q
    Front Immunol; 2023; 14():1242972. PubMed ID: 37809064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comprehensive pan-cancer analysis of the expression characteristics, prognostic value, and immune characteristics of
    Fei L; Lu Z; Xu Y; Hou G
    Front Genet; 2022; 13():920897. PubMed ID: 36035140
    [No Abstract]   [Full Text] [Related]  

  • 36. SLC10A3 Is a Prognostic Biomarker and Involved in Immune Infiltration and Programmed Cell Death in Lower Grade Glioma.
    Ma W; Mei P
    World Neurosurg; 2023 Oct; 178():e595-e640. PubMed ID: 37543196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
    Hao YP; Wang WY; Qiao Q; Li G
    Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Landscape of Whole-genome Alterations and Pathologic Features in Genitourinary Malignancies: An Analysis of the Cancer Genome Atlas.
    Ball MW; Gorin MA; Drake CG; Hammers HJ; Allaf ME
    Eur Urol Focus; 2017 Dec; 3(6):584-589. PubMed ID: 28753846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
    Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
    Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
    Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
    Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.